|
PXN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.708100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.310000E-02 |
| Normal-vs-Stage2 |
3.044000E-01 |
| Normal-vs-Stage3 |
1.151150E-01 |
| Normal-vs-Stage4 |
5.966300E-02 |
| Stage1-vs-Stage2 |
7.576000E-01 |
| Stage1-vs-Stage3 |
7.582200E-01 |
| Stage1-vs-Stage4 |
2.672000E-01 |
| Stage2-vs-Stage3 |
8.867000E-01 |
| Stage2-vs-Stage4 |
6.098000E-01 |
| Stage3-vs-Stage4 |
3.915000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.611500E-02 |
| Normal-vs-AfricanAmerican |
2.998400E-01 |
| Normal-vs-Asian |
3.290600E-01 |
| Caucasian-vs-AfricanAmerican |
7.619800E-01 |
| Caucasian-vs-Asian |
4.392200E-01 |
| AfricanAmerican-vs-Asian |
4.145600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.438200E-03 |
| Normal-vs-Female |
4.041400E-01 |
| Male-vs-Female |
5.265700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.126200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.416000E-02 |
| Normal-vs-Age(61-80Yrs) |
7.162100E-02 |
| Normal-vs-Age(81-100Yrs) |
1.982390E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.859400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.776600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.174400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.019400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.006300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.010000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.702900E-03 |
| Normal-vs-Grade 2 |
9.100400E-02 |
| Normal-vs-Grade 3 |
4.541000E-01 |
| Normal-vs-Grade 4 |
2.291700E-02 |
| Grade 1-vs-Grade 2 |
5.212800E-04 |
| Grade 1-vs-Grade 3 |
4.592600E-04 |
| Grade 1-vs-Grade 4 |
1.196970E-01 |
| Grade 2-vs-Grade 3 |
3.259200E-01 |
| Grade 2-vs-Grade 4 |
1.186040E-01 |
| Grade 3-vs-Grade 4 |
5.093600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.141000E-01 |
| Normal-vs-ccB subtype |
1.188460E-02 |
| ccA subtype-vs-ccB subtype |
2.034200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.112790E-01 |
| Normal-vs-N1 |
5.009200E-01 |
| N0-vs-N1 |
8.306800E-01 |
|
|
